ABSTRACT We have investigated factors affecting the probability that a woman with breast cancer participating in a mammographic screening programme will be diagnosed by the screen. Data from a large American case-control study, with subjects drawn from women participating in an annual screening programme, were used. During the screening programme, 409 cases were identified, the mode of diagnosis being screen detection for 331 and interval detection for 78. No significant relationships were found between mode of diagnosis and age, age at menarche, oral contraceptive use, age at first live birth, age at menopause or history of maternal breast cancer. There was a non-significant trend for particular mammographic patterns to be associated with interval detection. However relative risk of breast cancer and probability of interval detection were observed to increase about the time of the menopause. These results suggest that the 3 yearly mammography programme being introduced in the UK might be improved if an extra examination was included around the time of the menopause.
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A recurrent issue in breast cancer screening policy is whether there is a subgroup of women for whom screening is especially valuable. Such women might then become the sole recipients of screening, or they might receive more frequent screens than the rest of the population. Most researchers seek to identify women who possess a combination of risk factors which increases their risk of breast cancer, and then consider the effects of restricting screening to this subgroup. When only asymptomatic women are considered, conclusions are usually negative: no appreciable subgroup is at such high risk that differential screening policies would be worthwhile.'
A complementary question will be addressed in this paper. Cases alone are considered, drawn from follow up of participants in a breast cancer screening programme. Factors determining the mode of diagnosis (ie, at the screen or during the intervals between screens) are sought. This potentially allows the identification of women for whom the screening programme is proving to be relatively ineffective. Unfortunately, our conclusions are mostly negative and no obvious subgroup is identified. However, we do believe that both the relative risk of cancer and the relative effectiveness ofscreening need to be taken into consideration in the identification of any subset of women who might receive especially intensive screening.
The probability that a screening examination fails to identify a tumour that is present (the false negative rate) and the time that it takes for a tumour to develop through the stage in which it is detectable only by screening (the sojourn time) both affect the probability that a tumour is detected by screen rather than in the interval between screens. The methods in this paper cannot distinguish between these two situations.
The investigation reported here does throw some light on questions concerning the menopause and breast cancer risk which have been raised by Alexander and Roberts.2 Their suggestion that tumours develop more quickly during the menopause should be apparent from an increased proportion of interval cancers around this stage of life. This is because the quickly developing tumours will be more likely to progress through the pre-clinical state to clinical manifestation between screens. Evidence for this phenomenon is presented in this paper. The results in this section concern the probability that a case is interval detected rather than screen detected. Only the 409 cases detected during the John Whitehead and Jacqueline Cooper screening programme are considered; the postscreening cases are not included. Overall 78 cases (19%) were interval detected. The relationship between the probability of interval detection and various risk factors is investigated using logistic regression analysis. Values of the risk factors are drawn from the questionnaire completed on entry to the study, when these women were all asymptomatic. Only family history and age at menopause were subsequently updated. Wolfe pattern was not. Differences between probabilities are expressed in terms of odds ratios. (1985) , is once more apparent, the significance level lying between 5 and 10% (X2 = 6-04, df = 3, p < 0-1). Notice that the groups at higher risk of breast cancer (P2 and DY) are also the groups for which the screening programme is least effective.
Similar analyses investigated the effects on mode of diagnosis of age, age at menarche, age at menopause, previous personal history of non-breast cancer, breast cancer in mother, height, weight and breast size. None of these displayed a significant relationship with mode of diagnosis. Table 4 shows the relationship between clinic and mode of diagnosis. The probability of interval detection was least at Ann Arbor and Honolulu, with Seattle close behind and Tuscon showing a much greater probability. The first two centres were those using film-screen mammography and the latter two used xerography. An analysis was performed comparing these two techniques. The resulting odds ratio of interval detection for xerography relative to film-screen was estimated to be 2-24 (95% confidence interval 1-35, 3-71). This result was not substantially changed by adjustment for the pathology of the cancer. the definition is that the woman's last monthly period occurred between 2 and 12 months previously. They propose a model for the age incidence of breast cancer which includes an increased growth rate for existing tumours at the time of menopause as an explanation for their findings.
The Seattle data are not ideal for investigation of Alexander and Roberts' hypothesis. The precise definition of "menopause" is not explicit, but for each subject the "age at menopause" has been recorded. The age of both the case and her two matched controls at the time of the case's diagnosis can be found, and thus the number of years between menopause and diagnosis computed. The ages are recorded to the nearest year, and so their difference can be inaccurate by as much as one year in either direction. Alexander and Roberts were concerned with the effect of the menopausal state on breast cancer risk. We began by exploring this relationship using conditional logistic regression analysis of the data from both cases and controls. We then investigated the effect of the menopausal state on mode of diagnosis, which appears to be a more direct evaluation of the hypothesis of Alexander and Roberts. Figure 1 shows estimated relative risks for women classified by years from menopause to diagnosis, for the 1778 women for whom these data are available. The risk is adjusted for age by the matched nature of the data and the figure was prepared using the results of a conditional logistic regression analysis conducted using PROC LOGIST of the statistical computing package SAS. It is apparent that risk decreases with years from menopause to diagnosis, with a sharp rise and fall interrupting the pattern around the time of menopause itself.
Two possible sources of bias in this analysis must be noted. First, women contracting cancer before their menopause are more likely to die and thus be unable to supply a subsequent date of menopause. They will be excluded from the analysis, removing cases disproportionally from the pre-menopausal groups. Without this effect the underlying downward trend in the data would be stronger still. Second, diagnosis and treatment for breast cancer might involve the imposition of an unnatural menopause for some women. This will only affect women for whom the number of years from menopause to diagnosis takes a negative value: their time of subsequent menopause might be altered by treatment but not their menopausal status Years from menopause to diagnosis 6-10 11-15 16-20 >20 However, the probability of screen detection for a P2 woman with cancer under the annual screening policy of the Seattle Breast Cancer Study is 0-78 (Table 3) Thus, P(Screen Detection P2) = P(Screen Detection P2, BC) P(BC P2) = 0-78 P(BC P2) = 0-78 x 3*5 P (BC Ni) = 2-73 P(BC NI), whereas P(Screen Detection Ni) = 0-92 P(BC NI). 
